Why Moderna Stock Surged Today
The biotech could play a significant role in a national effort to combat cancer.
Overview
Shares of Moderna (NASDAQ:MRNA) jumped more than 14% on Friday, following reports of a major new cancer research initiative.
Image source: Getty Images.
The National Institutes of Health (NIH) plans to begin a campaign to fast-track cancer treatment research in December, according to a report by The New York Times. The program hopes to replicate the success of efforts to develop Covid-19 vaccines during the early stages of the pandemic.
Details
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.